X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (519) 519
index medicus (441) 441
female (295) 295
male (295) 295
drug administration schedule (259) 259
pharmacology & pharmacy (242) 242
pharmacokinetics (208) 208
middle aged (200) 200
adult (196) 196
aged (172) 172
dose-response relationship, drug (163) 163
dosing (137) 137
treatment outcome (125) 125
analysis (109) 109
animals (102) 102
adolescent (97) 97
oncology (96) 96
models, biological (84) 84
efficacy (83) 83
drug therapy (77) 77
young adult (77) 77
pharmacology (74) 74
child (73) 73
drug dosages (72) 72
therapy (72) 72
aged, 80 and over (71) 71
cancer (71) 71
dosage and administration (71) 71
pharmacodynamics (71) 71
research (68) 68
care and treatment (65) 65
medicine & public health (63) 63
safety (63) 63
children (62) 62
retrospective studies (61) 61
population pharmacokinetics (60) 60
pharmacology/toxicology (59) 59
anti-bacterial agents - administration & dosage (57) 57
administration, oral (54) 54
health aspects (53) 53
time factors (53) 53
drugs (52) 52
clinical trials (50) 50
computer simulation (50) 50
adherence (48) 48
dosing regimen (47) 47
anti-bacterial agents - pharmacokinetics (46) 46
child, preschool (46) 46
patients (45) 45
double-blind (44) 44
antibiotics (43) 43
pediatrics (43) 43
infectious diseases (42) 42
chemotherapy (41) 41
hematology (41) 41
infant (41) 41
studies (41) 41
article (39) 39
dosing frequency (38) 38
double-blind method (38) 38
mice (38) 38
risk factors (37) 37
biomedicine (36) 36
medicine, general & internal (36) 36
medicine, research & experimental (36) 36
models (36) 36
neoplasms - drug therapy (36) 36
area under curve (35) 35
dosing schedule (34) 34
internal medicine (34) 34
patient compliance (34) 34
toxicity (34) 34
impact (33) 33
infant, newborn (33) 33
half-life (32) 32
medicine (32) 32
microbiology (32) 32
rats (32) 32
clinical neurology (31) 31
dosing schedules (31) 31
infants (31) 31
prospective studies (31) 31
immunology (30) 30
medical research (30) 30
dosing regimens (29) 29
medication adherence (29) 29
pharmacy (29) 29
antineoplastic agents - administration & dosage (28) 28
body weight (28) 28
psychiatry (28) 28
disease (26) 26
dosage (26) 26
metabolic clearance rate (26) 26
adults (25) 25
algorithms (25) 25
infusions, intravenous (25) 25
metabolism (25) 25
population (25) 25
prevention (24) 24
age (23) 23
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer Research, ISSN 0008-5472, 07/2017, Volume 77, Issue 14, pp. 3908 - 3921
Journal Article
The Journal of Clinical Pharmacology, ISSN 0091-2700, 01/2013, Volume 53, Issue 1, pp. 14 - 20
Journal Article
Journal Article
Journal Article
BMC Public Health, ISSN 1471-2458, 10/2016, Volume 16, Issue 1, pp. 1103 - 11
Journal Article
Molecular Cancer Therapeutics, ISSN 1535-7163, 03/2017, Volume 16, Issue 3, pp. 428 - 439
Selinexor (KPT-330) is a first-in-class nuclear transport inhibitor currently in clinical trials as an anticancer agent. To determine how selinexor might... 
PROGNOSTIC-FACTOR | ONCOLOGY | ANTICANCER AGENTS | NUCLEAR EXPORT SIGNAL | ACUTE MYELOID-LEUKEMIA | SUPPRESSOR-CELLS | REGULATORY T | ANTITUMOR-ACTIVITY | CRM1 | CANCER | PANCREATIC-CARCINOMA | Neoplasms - metabolism | Immunomodulation - drug effects | Triazoles - administration & dosage | Humans | Antineoplastic Agents - administration & dosage | Immunity - drug effects | Melanoma, Experimental | T-Lymphocytes - metabolism | T-Lymphocytes - drug effects | Immunotherapy | CD8-Positive T-Lymphocytes - metabolism | Female | Homeostasis - drug effects | Hydrazines - administration & dosage | Disease Models, Animal | Antibody Formation - immunology | Receptors, Antigen, T-Cell - metabolism | Signal Transduction | Homeostasis - immunology | Mice, Knockout | Neoplasms - drug therapy | Xenograft Model Antitumor Assays | Animals | Neoplasms - immunology | Antibody Formation - drug effects | CD8-Positive T-Lymphocytes - drug effects | Biomarkers | T-Lymphocytes - immunology | Mice | CD8-Positive T-Lymphocytes - immunology | Neoplasms - pathology | Schedules | CD8 antigen | Clinical trials | Homeostasis | Effector cells | Cytotoxicity | Activation | Lymphocytes T | Dosage | Immunity | Thymus | Anticancer properties | Cell activation | Granzyme B | Lymphocytes | Bone marrow | Drug dosages | Medical research | Immunization | Melanoma | Inflammation | T cell receptors | Nuclear transport | Monocytes | Lymphocytes B | γ-Interferon | effector CD8 T cells | XPO1 | Selinexor | cancer immunotherapy | KPT-330 | combination therapy | dosing schedules | SINE compounds
Journal Article
Journal Article